Clinical Interests
  • Rhinology
  • Paranasal sinus disorders
  • Obstructive sleep apnea and sleep-disordered breathing
  • Endoscopic sinus surgery
  • Allergies
  • Sinusitis
Medical Education
  • MD, American University of Beirut
  • Residency, American University of Beirut Medical Center|Residency, Beth Israel Deaconess Medical Center|Residency, Massachusetts Eye and Ear Infirmary
  • Fellowship, Massachusetts Eye and Ear Infirmary
Board Certifications
  • Otolaryngology
Foreign Languages
  • Arabic
  • Boston: Massachusetts Eye and Ear Infirmary
Insurances Accepted
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Fallon Community HealthCare
  • Harvard Pilgrim Health Plan - other
  • Senior Whole Health
  • Tufts Health Plan

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


Dr. Busaba earned his MD from the American University of Beirut in Lebanon prior to joining the Massachusetts Eye and Ear Infirmary General Otolaryngology Service in 1991 as a resident. He is a fellowship-trained otolaryngologist who specializes in rhinology, paranasal sinus disorders, and obstructive sleep apnea and sleep-disordered breathing. He is board certified in Otolaryngology by the American Board of Otolaryngology.

Research & Publications

Research Summary

Dr. Busaba serves as principal investigator or co-investigator on several basic science and research projects. He is the principal investigator on a research project that aims at studying a possible connection between connexin genes mutations and chronic rhinosinusitis in both adults and children. He also serves as principal investigator on a clinical research project to determine the role of osteoplastic frontal sinus obliteration in the treatment of frontal sinus disease in the era of endoscopic sinus surgery. Furthermore, he is a co-investigator on a multi-institutional clinical research project to determine the safety and efficacy of a new tongue base implant that is being designed to treat OSA patients.

Silverman J, Prasittivatechakook K, and Busaba NY. Evidence Based Review of Endoscopic Frontal Sinus Surgery. Am J Rhinol Allergy. 2009; 23:59-62.

Kieff DA, Busaba NY. Reformation of conchae bullosae following treatment by crushing technique: implications for balloon sinuplasty. Laryngoscope. 2009;119:2454-6.

Yamin M, Holbrook EH, Gray ST, Harold R, Busaba NY, Sridhar A, Powell KJ, and Hamilos DL. Cigarette smoke combined with Toll-like receptor 3 (TLR3) signaling triggers exaggerated epithelial RANTED / CCL5 expression in chronic rhinosinusitis (CRS). J Allergy Clin Immun 2008; 122:1145-53.

Busaba NY, Sin HJ, and Salman SD. Impact of gender on clinical presentation of chronic rhinosinusitis with and without polyposis. J Laryngol Otol. 2008; 122:1180-4.

Busaba NY, Sin HJ, and Cunningham M. Connexin genes 26 and 30 mutation in patients with chronic rhinosinusitis. Laryngoscope 2008; 118: 310-3.

Busaba NY, Shaumberg DA. Predictors of prolonged length of stay after major elective head and neck surgery. Laryngoscope 2007; 117: 1756-63.

Busaba NY, Sin HJ, Faquin W. Correlation between Middle Turbinate and Ipsilateral Ethmoid Histopathology in Chronic Rhinosinusitis. Otolaryngol Head Neck Surg 2006; 134:250-4.

Kieff DA, Busaba NY. The efficacy of monteleukast in the treatment of nasal polyposis: A pilot study. Ann Otol Thinol Laryngol 2005; 114: 941-5.


Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114 - 3002
Phone: 617-573-3558
Fax: 617-573-3914